Sign in
4

Changes in Ownership

Seres Therapeutics, Inc. Filed Acc 0000899243-21-005254

Options or other derivatives

  • Chapman Marcus acquired 36,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Chapman Marcus

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-04 Grant or award : show line 1 in the form Restricted Stock Units +12,000 12,000 D
2021-02-04 Grant or award : show line 2 in the form Stock Option (Right to Buy) +24,000 24,000 D
Loading xslF345X03/doc4.xml…